News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
Roche Holding AG Says Full-Year Net Income Down 5 Percent At $9.3 Billion
February 4, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
AP -- Pharmaceuticals maker Roche Holding AG said Wednesday its net income for 2008 fell by 5 percent because of the strong Swiss franc, falling sales of its anti-flu drug and a drop in income from investments.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
Layoff Tracker
Kyverna Cut Off 16% of Staff in Q1
May 15, 2025
·
205 min read
·
BioSpace Editorial Staff
Obesity
Novo Doubles Down on Oral Obesity Meds With Septerna Deal Worth up to $2.4B
May 14, 2025
·
2 min read
·
Dan Samorodnitsky
Drug discovery
AbbVie Dives Further Into siRNA With $335M Upfront in ADARx Deal
May 14, 2025
·
2 min read
·
Annalee Armstrong
MASH
GSK Buys Phase III–Ready Liver Drug in Potential $2B Deal To Play in MASH Arena
May 14, 2025
·
2 min read
·
Tristan Manalac